Abstract
Recent years have witnessed increasing advances in gold nanoparticles (GNPs) for accurate and precise diagnosis and therapy. GNPs have great potential in translating into clinical nanomaterial-based products, predominantly attributed to their physicochemical and biological properties. Radiolabeling endows GNPs with high-sensitive imaging capacities in addition to providing potent therapeutic effects, which makes the development of radiolabeling nanotechnology highly desirable. In this review, we briefly describe the physicochemical properties of GNPs and radionuclides, then summarized radiolabeling methods utilized in radiolabeling GNPs, and discuss their whole-body pharmacokinetics and biodistribution. Finally, their current applications in clinical and molecular imaging and therapy are introduced.
Graphical Abstract
Similar content being viewed by others
References
Zanzonico P (2012) Principles of nuclear medicine imaging: planar, SPECT, PET, multi-modality, and autoradiography systems. Radiat Res 177:349–364. https://doi.org/10.1667/rr2577.1
Hutton BF (2014) The origins of SPECT and SPECT/CT. Eur J Nucl Med Mol Imaging 41(Suppl 1):S3-16. https://doi.org/10.1007/s00259-013-2606-5
Goel S, England CG, Chen F, Cai W (2017) Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics. Adv Drug Deliv Rev 113:157–176. https://doi.org/10.1016/j.addr.2016.08.001
Thiruppathi R, Mishra S, Ganapathy M, Padmanabhan P, Gulyas B (2017) Nanoparticle functionalization and its potentials for molecular imaging. Adv Sci (Weinh) 4:1600279. https://doi.org/10.1002/advs.201600279
Pellico J, Gawne PJ, de Rosales RT (2021) Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 50(5):3355–3423
Pratt EC, Shaffer TM, Grimm J (2016) Nanoparticles and radiotracers: advances toward radionanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:872–890. https://doi.org/10.1002/wnan.1402
Shaffer TM, Pratt EC, Grimm J (2017) Utilizing the power of Cerenkov light with nanotechnology. Nat Nanotechnol 12:106–117. https://doi.org/10.1038/nnano.2016.301
Man F, Gawne PJ, de Rosales RT (2019) Nuclear imaging of liposomal drug delivery systems: a critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 143:134–160. https://doi.org/10.1016/j.addr.2019.05.012
Goddard ZR, Marin MJ, Russell DA, Searcey M (2020) Active targeting of gold nanoparticles as cancer therapeutics. Chem Soc Rev 49:8774–8789. https://doi.org/10.1039/d0cs01121e
Kang H, Buchman JT, Rodriguez RS, Ring HL, He J, Bantz KC, Haynes CL (2019) Stabilization of silver and gold nanoparticles: preservation and improvement of plasmonic functionalities. Chem Rev 119:664–699. https://doi.org/10.1021/acs.chemrev.8b00341
Zhao J, Xue S, Ji R, Li B, Li J (2021) Localized surface plasmon resonance for enhanced electrocatalysis. Chem Soc Rev 50:12070–12097. https://doi.org/10.1039/d1cs00237f
Wilson AJ, Devasia D, Jain PK (2020) Nanoscale optical imaging in chemistry. Chem Soc Rev 49:6087–6112. https://doi.org/10.1039/d0cs00338g
Liu Y, Bhattarai P, Dai Z, Chen X (2019) Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. Chem Soc Rev 48:2053–2108. https://doi.org/10.1039/c8cs00618k
Vigderman L, Khanal BP, Zubarev ER (2012) Functional gold nanorods: synthesis, self-assembly, and sensing applications. Adv Mater 24(4811–4841):5014. https://doi.org/10.1002/adma.201201690
Alkilany AM, Thompson LB, Boulos SP, Sisco PN, Murphy CJ (2012) Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 64:190–199. https://doi.org/10.1016/j.addr.2011.03.005
Shanmugam V, Selvakumar S, Yeh CS (2014) Near-infrared light-responsive nanomaterials in cancer therapeutics. Chem Soc Rev 43:6254–6287. https://doi.org/10.1039/c4cs00011k
Meng D, Zheng R, Zhao Y, Zhang E, Dou L, Yang Y (2022) Near-infrared materials: the turning point of organic photovoltaics. Adv Mater 34:e2107330. https://doi.org/10.1002/adma.202107330
Vankayala R, Hwang KC (2018) Near-infrared-light-activatable nanomaterial-mediated phototheranostic nanomedicines: an emerging paradigm for cancer treatment. Adv Mater 30:e1706320. https://doi.org/10.1002/adma.201706320
Zhu S, Tian R, Antaris AL, Chen X, Dai H (2019) Near-infrared-II molecular dyes for cancer imaging and surgery. Adv Mater 31:e1900321. https://doi.org/10.1002/adma.201900321
Li B, Lin J, Huang P, Chen X (2022) Near-infrared probes for luminescence lifetime imaging. Nanotheranostics 6:91–102. https://doi.org/10.7150/ntno.63124
Xu C, Pu K (2021) Second near-infrared photothermal materials for combinational nanotheranostics. Chem Soc Rev 50:1111–1137. https://doi.org/10.1039/d0cs00664e
Chen G, Cao Y, Tang Y, Yang X, Liu Y, Huang D, Zhang Y, Li C, Wang Q (2020) Advanced near-infrared light for monitoring and modulating the spatiotemporal dynamics of cell functions in living systems. Adv Sci (Weinh) 7:1903783. https://doi.org/10.1002/advs.201903783
Fang J, Islam W, Maeda H (2020) Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers. Adv Drug Deliv Rev 157:142–160. https://doi.org/10.1016/j.addr.2020.06.005
Nel A, Ruoslahti E, Meng H (2017) New insights into “permeability” as in the enhanced permeability and retention effect of cancer nanotherapeutics. ACS Nano 11:9567–9569. https://doi.org/10.1021/acsnano.7b07214
Izci M, Maksoudian C, Manshian BB, Soenen SJ (2021) The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev 121:1746–1803. https://doi.org/10.1021/acs.chemrev.0c00779
Zhang L, Su H, Wang H, Li Q, Li X, Zhou C, Xu J, Chai Y, Liang X, Xiong L, Zhang C (2019) Tumor chemo-radiotherapy with rod-shaped and spherical gold nano probes: shape and active targeting both matter. Theranostics 9:1893–1908. https://doi.org/10.7150/thno.30523
Pretze M, von Kiedrowski V, Runge R, Freudenberg R, Hubner R, Davarci G, Schirrmacher R, Wangler C, Wangler B (2021) alphavbeta3-specific gold nanoparticles for fluorescence imaging of tumor angiogenesis. Nanomaterials (Basel) 11:138. https://doi.org/10.3390/nano11010138
Sun X, Huang X, Yan X, Wang Y, Guo J, Jacobson O, Liu D, Szajek LP, Zhu W, Niu G, Kiesewetter DO, Sun S, Chen X (2014) Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy. ACS Nano 8:8438–8446. https://doi.org/10.1021/nn502950t
Chakravarty R, Chakraborty S, Guleria A, Kumar C, Kunwar A, Nair KVV, Sarma HD, Dash A (2019) Clinical scale synthesis of intrinsically radiolabeled and cyclic RGD peptide functionalized (198)Au nanoparticles for targeted cancer therapy. Nucl Med Biol 72–73:1–10. https://doi.org/10.1016/j.nucmedbio.2019.05.005
Uhl P, Fricker G, Haberkorn U, Mier W (2015) Radionuclides in drug development. Drug Discov Today 20:198–208. https://doi.org/10.1016/j.drudis.2014.09.027
Papagiannopoulou D (2017) Technetium-99m radiochemistry for pharmaceutical applications. J Labelled Comp Radiopharm 60:502–520. https://doi.org/10.1002/jlcr.3531
Mushtaq S, Bibi A, Park JE, Jeon J (2021) Recent progress in technetium-99m-labeled nanoparticles for molecular imaging and cancer therapy. Nanomaterials (Basel) 11:3022. https://doi.org/10.3390/nano11113022
Eckelman WC (2009) Unparalleled contribution of technetium-99m to medicine over 5 decades. JACC Cardiovasc Imaging 2:364–368. https://doi.org/10.1016/j.jcmg.2008.12.013
Hayashi N, Izumi K, Sano F, Miyoshi Y, Uemura H, Kasuya T, Mukai A, Hata M, Inoue T (2015) Ten-year outcomes of I(1)(2)(5) low-dose-rate brachytherapy for clinically localized prostate cancer: a single-institution experience in Japan. World J Urol 33:1519–1526. https://doi.org/10.1007/s00345-015-1480-0
Vaidyanathan G, Zalutsky MR (2019) The radiopharmaceutical chemistry of the radioisotopes of iodine. Radiopharm Chem. https://doi.org/10.1007/978-3-319-98947-1_22
Ferris T, Carroll L, Jenner S, Aboagye EO (2021) Use of radioiodine in nuclear medicine-A brief overview. J Labelled Comp Radiopharm 64:92–108. https://doi.org/10.1002/jlcr.3891
Opacic T, Paefgen V, Lammers T, Kiessling F (2017) Status and trends in the development of clinical diagnostic agents. Wiley Interdiscip Rev Nanomed Nanobiotechnol. https://doi.org/10.1002/wnan.1441
Ng QK, Olariu CI, Yaffee M, Taelman VF, Marincek N, Krause T, Meier L, Walter MA (2014) Indium-111 labeled gold nanoparticles for in-vivo molecular targeting. Biomaterials 35:7050–7057. https://doi.org/10.1016/j.biomaterials.2014.04.098
Liu S (2008) Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev 60:1347–1370. https://doi.org/10.1016/j.addr.2008.04.006
van der Born D, Pees A, Poot AJ, Orru RVA, Windhorst AD, Vugts DJ (2017) Fluorine-18 labelled building blocks for PET tracer synthesis. Chem Soc Rev 46:4709–4773. https://doi.org/10.1039/c6cs00492j
Deng X, Rong J, Wang L, Vasdev N, Zhang L, Josephson L, Liang SH (2019) Chemistry for positron emission tomography: recent advances in (11) C-, (18) F-, (13) N-, and (15) O-labeling reactions. Angew Chem Int Ed Engl 58:2580–2605. https://doi.org/10.1002/anie.201805501
Klenner MA, Pascali G, Massi M, Fraser BH (2021) Fluorine-18 radiolabelling and photophysical characteristics of multimodal PET-fluorescence molecular probes. Chemistry 27:861–876. https://doi.org/10.1002/chem.202001402
Wang Y, Liu Y, Luehmann H, Xia X, Wan D, Cutler C, Xia Y (2013) Radioluminescent gold nanocages with controlled radioactivity for real-time in vivo imaging. Nano Lett 13:581–585. https://doi.org/10.1021/nl304111v
Tosato M, Dalla Tiezza M, May NV, Isse AA, Nardella S, Orian L, Verona M, Vaccarin C, Alker A, Macke H, Pastore P, Di Marco V (2021) Copper coordination chemistry of sulfur pendant cyclen derivatives: an attempt to hinder the reductive-induced demetalation in (64/67)Cu radiopharmaceuticals. Inorg Chem 60:11530–11547. https://doi.org/10.1021/acs.inorgchem.1c01550
Hickey JL, Lim S, Hayne DJ, Paterson BM, White JM, Villemagne VL, Roselt P, Binns D, Cullinane C, Jeffery CM, Price RI, Barnham KJ, Donnelly PS (2013) Diagnostic imaging agents for Alzheimer’s disease: copper radiopharmaceuticals that target Abeta plaques. J Am Chem Soc 135:16120–16132. https://doi.org/10.1021/ja4057807
Follacchio AG, De Feo SM, De Vincentis G, Monteleone F, Liberatore M (2018) Radiopharmaceuticals labelled with copper radionuclides: clinical results in human beings. Curr Radiopharm 11:22–33. https://doi.org/10.2174/1874471011666171211161851
Chen K, Cui M (2017) Recent progress in the development of metal complexes as beta-amyloid imaging probes in the brain. Medchemcomm 8:1393–1407. https://doi.org/10.1039/c7md00064b
Chakravarty R, Chakraborty S, Dash A (2016) (64)Cu(2+) ions as PET probe: an emerging paradigm in molecular imaging of cancer. Mol Pharm 13:3601–3612. https://doi.org/10.1021/acs.molpharmaceut.6b00582
Gutfilen B, Souza SA, Valentini G (2018) Copper-64: a real theranostic agent. Drug Des Devel Ther 12:3235–3245. https://doi.org/10.2147/DDDT.S170879
Silva WM, Ribeiro H, Taha-Tijerina JJ (2021) Potential production of theranostic boron nitride nanotubes ((64)Cu-BNNTs) radiolabeled by neutron capture. Nanomaterials (Basel) 11:2907. https://doi.org/10.3390/nano11112907
Boschi A, Martini P, Janevik-Ivanovska E, Duatti A (2018) The emerging role of copper-64 radiopharmaceuticals as cancer theranostics. Drug Discov Today 23:1489–1501. https://doi.org/10.1016/j.drudis.2018.04.002
Samim A, Tytgat GAM, Bleeker G, Wenker STM, Chatalic KLS, Poot AJ, Tolboom N, van Noesel MM, Lam M, de Keizer B (2021) Nuclear medicine imaging in neuroblastoma: current status and new developments. J Pers Med 11:2907. https://doi.org/10.3390/jpm11040270
Alves F, Alves VH, Neves ACB, Carmo SJCd, Nactergal B, Hellas V, Kral E, Gonçalves-Gameiro C, Abrunhosa AJ (2017) Cyclotron production of Ga-68 for human use from liquid targets: from theory to practice. AIP Conf Proc 1845:020001. https://doi.org/10.1063/1.4983532
Brandt M, Cardinale J, Aulsebrook ML, Gasser G, Mindt TL (2018) An overview of PET radiochemistry, Part 2: radiometals. J Nucl Med 59:1500–1506. https://doi.org/10.2967/jnumed.117.190801
Perera M, Papa N, Roberts M, Williams M, Udovicich C, Vela I, Christidis D, Bolton D, Hofman MS, Lawrentschuk N, Murphy DG (2020) Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer-updated diagnostic utility, sensitivity, specificity, and distribution of prostate-specific membrane antigen-avid lesions: a systematic review and meta-analysis. Eur Urol 77:403–417. https://doi.org/10.1016/j.eururo.2019.01.049
Virgolini I, Ambrosini V, Bomanji JB, Baum RP, Fanti S, Gabriel M, Papathanasiou ND, Pepe G, Oyen W, De Cristoforo C, Chiti A (2010) Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. Eur J Nucl Med Mol Imaging 37:2004–2010. https://doi.org/10.1007/s00259-010-1512-3
Bhatt NB, Pandya DN, Wadas TJ (2018) Recent advances in Zirconium-89 chelator development. Molecules 23:638. https://doi.org/10.3390/molecules23030638
Fischer G, Seibold U, Schirrmacher R, Wängler B, Wängler C (2013) 89Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges. Molecules 18:6469–6490
Kumar K, Ghosh A (2021) Radiochemistry, production processes, labeling methods, and immuno PET imaging pharmaceuticals of Iodine-124. Molecules 26:414. https://doi.org/10.3390/molecules26020414
Aboian MS, Huang SY, Hernandez-Pampaloni M, Hawkins RA, VanBrocklin HF, Huh Y, Vo KT, Gustafson WC, Matthay KK, Seo Y (2021) (124)I-MIBG PET/CT to monitor metastatic disease in children with relapsed neuroblastoma. J Nucl Med 62:43–47. https://doi.org/10.2967/jnumed.120.243139
Cascini GL, Niccoli Asabella A, Notaristefano A, Restuccia A, Ferrari C, Rubini D, Altini C, Rubini G (2014) 124 Iodine: a longer-life positron emitter isotope-new opportunities in molecular imaging. Biomed Res Int 2014:672094. https://doi.org/10.1155/2014/672094
Pei P, Liu T, Shen W, Liu Z, Yang K (2021) Biomaterial-mediated internal radioisotope therapy. Mater Horiz 8:1348–1366. https://doi.org/10.1039/d0mh01761b
Hosseini SF, Sadeghi M, Aboudzadeh MR, Mohseni M (2016) Production and modeling of radioactive gold nanoparticles in Tehran research reactor. Appl Radiat Isot 118:361–365. https://doi.org/10.1016/j.apradiso.2016.10.004
Al-Yasiri AY, Khoobchandani M, Cutler CS, Watkinson L, Carmack T, Smith CJ, Kuchuk M, Loyalka SK, Lugao AB, Katti KV (2017) Mangiferin functionalized radioactive gold nanoparticles (MGF-(198)AuNPs) in prostate tumor therapy: green nanotechnology for production, in vivo tumor retention and evaluation of therapeutic efficacy. Dalton Trans 46:14561–14571. https://doi.org/10.1039/c7dt00383h
Xuan S, de Barros A, Nunes RC, Ricci-Junior E, da Silva AX, Sahid M, Alencar LMR, Dos Santos CC, Morandi V, Alexis F, Iram SH, Santos-Oliveira R (2020) Radioactive gold nanocluster (198-AuNCs) showed inhibitory effects on cancer cells lines. Artif Cells Nanomed Biotechnol 48:1214–1221. https://doi.org/10.1080/21691401.2020.1821698
Rambanapasi C, Barnard N, Grobler A, Buntting H, Sonopo M, Jansen D, Jordaan A, Steyn H, Zeevaart JR (2015) Dual radiolabeling as a technique to track nanocarriers: the case of gold nanoparticles. Molecules 20:12863–12879. https://doi.org/10.3390/molecules200712863
Ge J, Zhang Q, Zeng J, Gu Z, Gao M (2020) Radiolabeling nanomaterials for multimodality imaging: new insights into nuclear medicine and cancer diagnosis. Biomaterials 228:119553. https://doi.org/10.1016/j.biomaterials.2019.119553
Wang Y, Liu Y, Luehmann H, Xia X, Brown P, Jarreau C, Welch M, Xia Y (2012) Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imaging. ACS Nano 6:5880–5888. https://doi.org/10.1021/nn300464r
Cheng K, Kothapalli SR, Liu H, Koh AL, Jokerst JV, Jiang H, Yang M, Li J, Levi J, Wu JC, Gambhir SS, Cheng Z (2014) Construction and validation of nano gold tripods for molecular imaging of living subjects. J Am Chem Soc 136:3560–3571. https://doi.org/10.1021/ja412001e
Yang M, Cheng K, Qi S, Liu H, Jiang Y, Jiang H, Li J, Chen K, Zhang H, Cheng Z (2013) Affibody modified and radiolabeled gold-iron oxide hetero-nanostructures for tumor PET, optical and MR imaging. Biomaterials 34:2796–2806. https://doi.org/10.1016/j.biomaterials.2013.01.014
Frigell J, Garcia I, Gomez-Vallejo V, Llop J, Penades S (2014) 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation. J Am Chem Soc 136:449–457. https://doi.org/10.1021/ja411096m
Kreyling WG, Abdelmonem AM, Ali Z, Alves F, Geiser M, Haberl N, Hartmann R, Hirn S, de Aberasturi DJ, Kantner K, Khadem-Saba G, Montenegro J-M, Rejman J, Rojo T, de Larramendi IR, Ufartes R, Wenk A, Parak WJ (2015) In vivo integrity of polymer-coated gold nanoparticles. Nat Nanotechnol 10:619–623. https://doi.org/10.1038/nnano.2015.111
Li X, Xiong Z, Xu X, Luo Y, Peng C, Shen M, Shi X (2016) 99mTc-labeled multifunctional low-generation dendrimer-entrapped gold nanoparticles for targeted SPECT/CT dual-mode imaging of tumors. ACS Appl Mater Interfaces 8:19883–19891. https://doi.org/10.1021/acsami.6b04827
Zhu J, Chin J, Wangler C, Wangler B, Lennox RB, Schirrmacher R (2014) Rapid (18)F-labeling and loading of PEGylated gold nanoparticles for in vivo applications. Bioconjug Chem 25:1143–1150. https://doi.org/10.1021/bc5001593
Kamal R, Chadha VD, Dhawan DK (2018) Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles ((99m)Tc-Res-AuNP) in colon cancer tissue. Nanomedicine 14:1059–1071. https://doi.org/10.1016/j.nano.2018.01.008
Zhang Y, Zhang Y, Yin L, Xia X, Hu F, Liu Q, Qin C, Lan X (2017) Synthesis and Bioevaluation of Iodine-131 directly labeled cyclic RGD-PEGylated gold nanorods for tumor-targeted imaging. Contrast Media Mol Imaging 2017:6081724. https://doi.org/10.1155/2017/6081724
Hu H, Huang P, Weiss OJ, Yan X, Yue X, Zhang MG, Tang Y, Nie L, Ma Y, Niu G, Wu K, Chen X (2014) PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters. Biomaterials 35:9868–9876. https://doi.org/10.1016/j.biomaterials.2014.08.038
Chakravarty R, Chakraborty S, Guleria A, Shukla R, Kumar C, Vimalnath Nair KV, Sarma HD, Tyagi AK, Dash A (2018) Facile one-pot synthesis of intrinsically radiolabeled and cyclic RGD conjugated 199Au nanoparticles for potential use in nanoscale brachytherapy. Ind Eng Chem Res 57:14337–14346. https://doi.org/10.1021/acs.iecr.8b02526
Lee SB, Lee SW, Jeong SY, Yoon G, Cho SJ, Kim SK, Lee IK, Ahn BC, Lee J, Jeon YH (2017) Engineering of radioiodine-labeled gold core-shell nanoparticles as efficient nuclear medicine imaging agents for trafficking of dendritic cells. ACS Appl Mater Interfaces 9:8480–8489. https://doi.org/10.1021/acsami.6b14800
Lee SB, Ahn SB, Lee S-W, Jeong SY, Ghilsuk Y, Ahn B-C, Kim E-M, Jeong H-J, Lee J, Lim D-K, Jeon YH (2016) Radionuclide-embedded gold nanoparticles for enhanced dendritic cell-based cancer immunotherapy, sensitive and quantitative tracking of dendritic cells with PET and Cerenkov luminescence. NPG Asia Mater 8:e281–e281. https://doi.org/10.1038/am.2016.80
Ranjbar Bahadori S, Mulgaonkar A, Hart R, Wu CY, Zhang D, Pillai A, Hao Y, Sun X (2021) Radiolabeling strategies and pharmacokinetic studies for metal based nanotheranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 13:e1671. https://doi.org/10.1002/wnan.1671
Lattuada L, Barge A, Cravotto G, Giovenzana GB, Tei L (2011) The synthesis and application of polyamino polycarboxylic bifunctional chelating agents. Chem Soc Rev 40:3019–3049. https://doi.org/10.1039/c0cs00199f
Pant K, Sedlacek O, Nadar RA, Hruby M, Stephan H (2017) Radiolabelled polymeric materials for imaging and treatment of cancer: Quo vadis? Adv Healthc Mater 6:1601115. https://doi.org/10.1002/adhm.201601115
Enrique MA, Mariana OR, Mirshojaei SF, Ahmadi A (2015) Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment. J Drug Target 23:191–201. https://doi.org/10.3109/1061186X.2014.988216
White CA, Akbari A, Allen C, Day AG, Norman PA, Holland D, Adams MA, Knoll GA (2021) Simultaneous glomerular filtration rate determination using inulin, iohexol, and (99m)Tc-DTPA demonstrates the need for customized measurement protocols. Kidney Int 99:957–966. https://doi.org/10.1016/j.kint.2020.06.044
Boros E, Cawthray JF, Ferreira CL, Patrick BO, Adam MJ, Orvig C (2012) Evaluation of the H2)dedpa scaffold and its cRGDyK conjugates for labeling with 64Cu. Inorg Chem 51:6279–6284. https://doi.org/10.1021/ic300482x
Rischpler C, Beck TI, Okamoto S, Schlitter AM, Knorr K, Schwaiger M, Gschwend J, Maurer T, Meyer PT, Eiber M (2018) (68)Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging. J Nucl Med 59:1406–1411. https://doi.org/10.2967/jnumed.117.204677
Price EW, Orvig C (2014) Matching chelators to radiometals for radiopharmaceuticals. Chem Soc Rev 43:260–290. https://doi.org/10.1039/c3cs60304k
Kostelnik TI, Orvig C (2019) Radioactive main group and rare earth metals for imaging and therapy. Chem Rev 119:902–956. https://doi.org/10.1021/acs.chemrev.8b00294
Guerrero S, Herance JR, Rojas S, Mena JF, Gispert JD, Acosta GA, Albericio F, Kogan MJ (2012) Synthesis and in vivo evaluation of the biodistribution of a 18F-labeled conjugate gold-nanoparticle-peptide with potential biomedical application. Bioconjug Chem 23:399–408. https://doi.org/10.1021/bc200362a
Steen EJL, Edem PE, Norregaard K, Jorgensen JT, Shalgunov V, Kjaer A, Herth MM (2018) Pretargeting in nuclear imaging and radionuclide therapy: improving efficacy of theranostics and nanomedicines. Biomaterials 179:209–245. https://doi.org/10.1016/j.biomaterials.2018.06.021
Kumar K (2022) Radioiodine labeling reagents and methods for new chemical entities and biomolecules. Cancer Biother Radiopharm 37:173–185. https://doi.org/10.1089/cbr.2021.0233
Agarwal A, Shao X, Rajian JR, Zhang H, Chamberland DL, Kotov NA, Wang X (2011) Dual-mode imaging with radiolabeled gold nanorods. J Biomed Opt 16:051307. https://doi.org/10.1117/1.3580277
Sun X, Cai W, Chen X (2015) Positron emission tomography imaging using radiolabeled inorganic nanomaterials. Acc Chem Res 48:286–294. https://doi.org/10.1021/ar500362y
Liu TW, MacDonald TD, Shi J, Wilson BC, Zheng G (2012) Intrinsically copper-64-labeled organic nanoparticles as radiotracers. Angew Chem Int Ed Engl 51:13128–13131. https://doi.org/10.1002/anie.201206939
Goel S, Chen F, Ehlerding EB, Cai W (2014) Intrinsically radiolabeled nanoparticles: an emerging paradigm. Small 10:3825–3830. https://doi.org/10.1002/smll.201401048
Zhao Y, Sultan D, Detering L, Luehmann H, Liu Y (2014) Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of (6)(4)Cu-Au alloy nanoclusters. Nanoscale 6:13501–13509. https://doi.org/10.1039/c4nr04569f
Zhao Y, Sultan D, Detering L, Cho S, Sun G, Pierce R, Wooley KL, Liu Y (2014) Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. Angew Chem Int Ed Engl 53:156–159. https://doi.org/10.1002/anie.201308494
Pretze M, van der Meulen NP, Wangler C, Schibli R, Wangler B (2019) Targeted (64) Cu-labeled gold nanoparticles for dual imaging with positron emission tomography and optical imaging. J Labelled Comp Radiopharm 62:471–482. https://doi.org/10.1002/jlcr.3736
Frellsen AF, Hansen AE, Jolck RI, Kempen PJ, Severin GW, Rasmussen PH, Kjaer A, Jensen AT, Andresen TL (2016) Mouse Positron emission tomography study of the biodistribution of gold nanoparticles with different surface coatings using embedded Copper-64. ACS Nano 10:9887–9898. https://doi.org/10.1021/acsnano.6b03144
Iram F, Iqbal MS, Khan IU, Rasheed R, Khalid A, Khalid M, Aftab S, Shakoori AR (2020) Synthesis and biodistribution study of biocompatible 198Au nanoparticles by use of arabinoxylan as reducing and stabilizing agent. Biol Trace Elem Res 193:282–293. https://doi.org/10.1007/s12011-019-01700-y
Souza B, Ribeiro E, Silva de Barros AO, Pijeira MSO, Kenup-Hernandes HO, Ricci-Junior E, Diniz Filho JFS, Dos Santos CC, Alencar LMR, Attia MF, Gemini-Piperni S, Santos-Oliveira R (2022) Nanomicelles of radium dichloride [(223)Ra]RaCl(2) Co-loaded with radioactive gold [(198)Au]Au nanoparticles for targeted alpha-beta radionuclide therapy of osteosarcoma. Polymers (Basel) 14(7):1405. https://doi.org/10.3390/polym14071405
Zhao Y, Pang B, Luehmann H, Detering L, Yang X, Sultan D, Harpstrite S, Sharma V, Cutler CS, Xia Y, Liu Y (2016) Gold nanoparticles doped with (199) Au atoms and their use for targeted cancer imaging by SPECT. Adv Healthc Mater 5:928–935. https://doi.org/10.1002/adhm.201500992
Bourquin J, Milosevic A, Hauser D, Lehner R, Blank F, Petri-Fink A, Rothen-Rutishauser B (2018) Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv Mater 30:e1704307. https://doi.org/10.1002/adma.201704307
Weber C, Morsbach S, Landfester K (2019) Possibilities and limitations of different separation techniques for the analysis of the protein corona. Angew Chem Int Ed Engl 58:12787–12794. https://doi.org/10.1002/anie.201902323
Cai R, Chen C (2019) the crown and the scepter: roles of the protein corona in nanomedicine. Adv Mater 31:1805740. https://doi.org/10.1002/adma.201805740
Madathiparambil Visalakshan R, Gonzalez Garcia LE, Benzigar MR, Ghazaryan A, Simon J, Mierczynska-Vasilev A, Michl TD, Vinu A, Mailander V, Morsbach S, Landfester K, Vasilev K (2020) The influence of nanoparticle shape on protein corona formation. Small 16:e2000285. https://doi.org/10.1002/smll.202000285
Bewersdorff T, Glitscher EA, Bergueiro J, Eravci M, Miceli E, Haase A, Calderon M (2020) The influence of shape and charge on protein corona composition in common gold nanostructures. Mater Sci Eng C Mater Biol Appl 117:111270. https://doi.org/10.1016/j.msec.2020.111270
Pelaz B, del Pino P, Maffre P, Hartmann R, Gallego M, Rivera-Fernandez S, de la Fuente JM, Nienhaus GU, Parak WJ (2015) Surface functionalization of nanoparticles with polyethylene glycol: effects on protein adsorption and cellular uptake. ACS Nano 9:6996–7008. https://doi.org/10.1021/acsnano.5b01326
Donahue ND, Acar H, Wilhelm S (2019) Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv Drug Deliv Rev 143:68–96. https://doi.org/10.1016/j.addr.2019.04.008
Clogston JD (2021) The importance of nanoparticle physicochemical characterization for immunology research: what we learned and what we still need to understand. Adv Drug Deliv Rev 176:113897. https://doi.org/10.1016/j.addr.2021.113897
Agarwal R, Singh V, Jurney P, Shi L, Sreenivasan SV, Roy K (2013) Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci 110:17247–17252. https://doi.org/10.1073/pnas.1305000110
Ding L, Yao C, Yin X, Li C, Huang Y, Wu M, Wang B, Guo X, Wang Y, Wu M (2018) Size, shape, and protein corona determine cellular uptake and removal mechanisms of gold nanoparticles. Small 14:e1801451. https://doi.org/10.1002/smll.201801451
Gong L, He K, Liu J (2021) Concentration-dependent subcellular distribution of ultrasmall near-infrared-emitting gold nanoparticles. Angew Chem Int Ed Engl 60:5739–5743. https://doi.org/10.1002/anie.202014833
Choo P, Liu T, Odom TW (2021) Nanoparticle shape determines dynamics of targeting nanoconstructs on cell membranes. J Am Chem Soc 143:4550–4555. https://doi.org/10.1021/jacs.1c00850
Akiyama Y, Mori T, Katayama Y, Niidome T (2012) Conversion of rod-shaped gold nanoparticles to spherical forms and their effect on biodistribution in tumor-bearing mice. Nanoscale Res Lett 7:565. https://doi.org/10.1186/1556-276X-7-565
Black KC, Wang Y, Luehmann HP, Cai X, Xing W, Pang B, Zhao Y, Cutler CS, Wang LV, Liu Y, Xia Y (2014) Radioactive 198Au-doped nanostructures with different shapes for in vivo analyses of their biodistribution, tumor uptake, and intratumoral distribution. ACS Nano 8:4385–4394. https://doi.org/10.1021/nn406258m
Yu M, Xu J, Zheng J (2019) Renal clearable luminescent gold nanoparticles: from the bench to the clinic. Angew Chem Int Ed Engl 58:4112–4128. https://doi.org/10.1002/anie.201807847
Du B, Jiang X, Das A, Zhou Q, Yu M, Jin R, Zheng J (2017) Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime. Nat Nanotechnol 12:1096–1102. https://doi.org/10.1038/nnano.2017.170
Zhang B, Chen J, Cao Y, Chai OJH, Xie J (2021) Ligand design in ligand-protected gold nanoclusters. Small 17:e2004381. https://doi.org/10.1002/smll.202004381
Zheng B, Wu Q, Jiang Y, Hou M, Zhang P, Liu M, Zhang L, Li B, Zhang C (2021) One-pot synthesis of (68)Ga-doped ultrasmall gold nanoclusters for PET/CT imaging of tumors. Mater Sci Eng C Mater Biol Appl 128:112291. https://doi.org/10.1016/j.msec.2021.112291
Lee SB, Kumar D, Li Y, Lee IK, Cho SJ, Kim SK, Lee SW, Jeong SY, Lee J, Jeon YH (2018) PEGylated crushed gold shell-radiolabeled core nanoballs for in vivo tumor imaging with dual positron emission tomography and Cerenkov luminescent imaging. J Nanobiotechnol 16:41. https://doi.org/10.1186/s12951-018-0366-x
Pratt EC, Shaffer TM, Zhang Q, Drain CM, Grimm J (2018) Nanoparticles as multimodal photon transducers of ionizing radiation. Nat Nanotechnol 13:418–426. https://doi.org/10.1038/s41565-018-0086-2
Das S, Thorek DL, Grimm J (2014) Cerenkov imaging. Adv Cancer Res 124:213–234. https://doi.org/10.1016/B978-0-12-411638-2.00006-9
Zhang Q, Pratt EC, Tamura R, Ogirala A, Hsu HT, Farahmand N, O’Brien S, Grimm J (2021) Ultrasmall downconverting nanoparticle for enhanced cerenkov imaging. Nano Lett 21:4217–4224. https://doi.org/10.1021/acs.nanolett.1c00049
Thorek D, Robertson R, Bacchus WA, Hahn J, Rothberg J, Beattie BJ, Grimm J (2012) Cerenkov imaging - a new modality for molecular imaging. Am J Nucl Med Mol Imaging 2:163–173
Genovese D, Petrizza L, Prodi L, Rampazzo E, De Sanctis F, Spinelli AE, Boschi F, Zaccheroni N (2020) Tandem dye-doped nanoparticles for NIR imaging via cerenkov resonance energy transfer. Front Chem 8:71. https://doi.org/10.3389/fchem.2020.00071
Guo J, Feng K, Wu W, Ruan Y, Liu H, Han X, Shao G, Sun X (2021) Smart (131) I-labeled self-illuminating photosensitizers for deep tumor therapy. Angew Chem Int Ed Engl 60:21884–21889. https://doi.org/10.1002/anie.202107231
Heuvel JO, van der Poel HG, van Leeuwen PJ, Bekers EM, Grootendorst MR, Vyas KN, Slump CH, Stokkel MP (2022) Cerenkov luminescence imaging in prostate cancer: not the only light that shines. J Nucl Med 63(1):29–35. https://doi.org/10.2967/jnumed.120.260034
Zhao Y, Shaffer TM, Das S, Perez-Medina C, Mulder WJ, Grimm J (2017) Near-infrared quantum dot and (89)Zr dual-labeled nanoparticles for in vivo cerenkov imaging. Bioconjug Chem 28:600–608. https://doi.org/10.1021/acs.bioconjchem.6b00687
Kotagiri N, Sudlow GP, Akers WJ, Achilefu S (2015) Breaking the depth dependency of phototherapy with Cerenkov radiation and low-radiance-responsive nanophotosensitizers. Nat Nanotechnol 10:370–379. https://doi.org/10.1038/nnano.2015.17
Lee SB, Yoon G, Lee SW, Jeong SY, Ahn BC, Lim DK, Lee J, Jeon YH (2016) Combined positron emission tomography and cerenkov luminescence imaging of sentinel lymph nodes using PEGylated radionuclide-embedded gold nanoparticles. Small 12:4894–4901. https://doi.org/10.1002/smll.201601721
Spinelli AE, D’Ambrosio D, Calderan L, Marengo M, Sbarbati A, Boschi F (2010) Cerenkov radiation allows in vivo optical imaging of positron emitting radiotracers. Phys Med Biol 55:483–495. https://doi.org/10.1088/0031-9155/55/2/010
Robertson R, Germanos MS, Li C, Mitchell GS, Cherry SR, Silva MD (2009) Optical imaging of Cerenkov light generation from positron-emitting radiotracers. Phys Med Biol 54:N355-365. https://doi.org/10.1088/0031-9155/54/16/N01
Black KC, Ibricevic A, Gunsten SP, Flores JA, Gustafson TP, Raymond JE, Samarajeewa S, Shrestha R, Felder SE, Cai T, Shen Y, Lobs AK, Zhegalova N, Sultan DH, Berezin M, Wooley KL, Liu Y, Brody SL (2016) In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Cerenkov imaging. Biomaterials 98:53–63. https://doi.org/10.1016/j.biomaterials.2016.04.040
Thorek DL, Riedl CC, Grimm J (2014) Clinical Cerenkov luminescence imaging of (18)F-FDG. J Nucl Med 55:95–98. https://doi.org/10.2967/jnumed.113.127266
Fu Q, Zhu R, Song J, Yang H, Chen X (2019) Photoacoustic imaging: contrast agents and their biomedical applications. Adv Mater 31:e1805875. https://doi.org/10.1002/adma.201805875
Moore C, Chen F, Wang J, Jokerst JV (2019) Listening for the therapeutic window: advances in drug delivery utilizing photoacoustic imaging. Adv Drug Deliv Rev 144:78–89. https://doi.org/10.1016/j.addr.2019.07.003
Jiang Y, Pu K (2017) Advanced photoacoustic imaging applications of near-infrared absorbing organic nanoparticles. Small 13:1700710. https://doi.org/10.1002/smll.201700710
Du J, Yang S, Qiao Y, Lu H, Dong H (2021) Recent progress in near-infrared photoacoustic imaging. Biosens Bioelectron 191:113478. https://doi.org/10.1016/j.bios.2021.113478
Xu C, Chen F, Valdovinos HF, Jiang D, Goel S, Yu B, Sun H, Barnhart TE, Moon JJ, Cai W (2018) Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. Biomaterials 165:56–65. https://doi.org/10.1016/j.biomaterials.2018.02.043
Huang Q, Zhang S, Zhang H, Han Y, Liu H, Ren F, Sun Q, Li Z, Gao M (2019) Boosting the radiosensitizing and photothermal performance of Cu2- xse nanocrystals for synergetic radiophotothermal therapy of orthotopic breast cancer. ACS Nano 13:1342–1353. https://doi.org/10.1021/acsnano.8b06795
Lusic H, Grinstaff MW (2013) X-ray-computed tomography contrast agents. Chem Rev 113:1641–1666. https://doi.org/10.1021/cr200358s
Liu Y, Ai K, Lu L (2012) Nanoparticulate X-ray computed tomography contrast agents: from design validation to in vivo applications. Acc Chem Res 45:1817–1827. https://doi.org/10.1021/ar300150c
Jakhmola A, Anton N, Vandamme TF (2012) Inorganic nanoparticles based contrast agents for X-ray computed tomography. Adv Healthc Mater 1:413–431. https://doi.org/10.1002/adhm.201200032
Li X, Wang C, Tan H, Cheng L, Liu G, Yang Y, Zhao Y, Zhang Y, Li Y, Zhang C, Xiu Y, Cheng D, Shi H (2016) Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques. Biomaterials 108:71–80. https://doi.org/10.1016/j.biomaterials.2016.08.048
Simon M, Jorgensen JT, Melander F, Andresen TL, Christensen A, Kjaer A (2021) Photothermal therapy as adjuvant to surgery in an orthotopic mouse model of human fibrosarcoma. Cancers (Basel) 13:5820. https://doi.org/10.3390/cancers13225820
Lee HP, Gaharwar AK (2020) Light-responsive inorganic biomaterials for biomedical applications. Adv Sci (Weinh) 7:2000863. https://doi.org/10.1002/advs.202000863
Lee SB, Lee JE, Cho SJ, Chin J, Kim SK, Lee IK, Lee SW, Lee J, Jeon YH (2019) Crushed gold shell nanoparticles labeled with radioactive iodine as a theranostic nanoplatform for macrophage-mediated photothermal therapy. Nanomicro Lett 11:36. https://doi.org/10.1007/s40820-019-0266-0
Cheng D, Gong J, Wang P, Zhu J, Yu N, Zhao J, Zhang Q, Li J (2021) (131)I-Labeled gold nanoframeworks for radiotherapy-combined second near-infrared photothermal therapy of cancer. J Mater Chem B 9:9316–9323. https://doi.org/10.1039/d1tb02115j
Pulagam KR, Henriksen-Lacey M, Uribe B, Renero-Lecuna C, Kumar J, Charalampopoulou A, Facoetti A, Protti N, Gomez-Vallejo V, Baz Z, Kumar V, Sanchez-Iglesias A, Altieri S, Cossio U, Di Silvio D, Martinez-Villacorta AM, Ruiz de Angulo A, Rejc L, Liz-Marzan LM, Llop J (2021) In vivo evaluation of multifunctional gold nanorods for boron neutron capture and photothermal therapies. ACS Appl Mater Interfaces 13:49589–49601. https://doi.org/10.1021/acsami.0c17575
Axiak-Bechtel SM, Upendran A, Lattimer JC, Kelsey J, Cutler CS, Selting KA, Bryan JN, Henry CJ, Boote E, Tate DJ, Bryan ME, Katti KV, Kannan R (2014) Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer. Int J Nanomed 9:5001–5011. https://doi.org/10.2147/IJN.S67333
Acknowledgements
We are grateful to this work is supported by the General project of Wuxi Municipal Health Commission (M202230) and the Open Program of NHC Key Laboratory of Nuclear Medicine and Jiangsu Key Laboratory of Molecular Nuclear Medicine (KF201905).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gao, Q., Chen, F. Multimodal radiolabeled gold nanoparticle molecular probes: synthesis, imaging, and applications. J Radioanal Nucl Chem 332, 1625–1645 (2023). https://doi.org/10.1007/s10967-023-08895-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-023-08895-4